Olema Pharmaceuticals Balance Sheet
NASDAQ: OLMAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Olema Pharmaceuticals financial position
At the end of fiscal 2025, Olema Pharmaceuticals reported total assets of $533.4 million, up 18.3% from a year earlier against total liabilities of $54.9 million. Shareholders' equity stood at $478.6 million, or 89.7% of assets. The company held $48.3 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 9.95, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Olema Pharmaceuticals balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 48.30M | 139.48M | 68.54M | 23.70M | 13.81M | 338.55M | 68.00K |
| Short-Term Investments | 457.14M | 294.61M | 193.27M | 180.72M | 273.44M | — | — |
| Total Current Assets | 515.45M | 438.47M | 266.51M | 208.90M | 290.69M | 342.14M | — |
| Property, Plant & Equipment | 274.00K | 746.00K | 968.00K | 1.48M | 1.47M | 75.00K | — |
| Total Assets | 533.43M | 450.98M | 276.94M | 215.65M | 295.94M | 342.72M | — |
| Accounts Payable | 9.25M | 4.46M | 2.70M | 374.00K | 23.00K | 719.00K | — |
| Total Current Liabilities | 51.80M | 41.76M | 21.62M | 16.55M | 9.02M | 4.58M | — |
| Total Liabilities | 54.87M | 42.02M | 23.05M | 18.10M | 11.38M | 4.58M | — |
| Shareholders' Equity | 478.56M | 408.96M | 253.90M | 197.55M | 284.57M | 338.14M | -10.59M |
| Retained Earnings | -597.56M | -435.11M | -305.63M | -208.98M | -104.19M | -33.09M | — |
| Net Cash (Debt) | 505.44M | 434.09M | 261.81M | 204.42M | 287.25M | 338.55M | 68.00K |
| Shares Outstanding | 81.38M | 74.31M | 54.99M | 40.29M | 39.80M | 39.31M | — |
This table shows 7 annual periods of Olema Pharmaceuticals's balance sheet, from FY 2025 back to FY 2019, across 12 line items including cash & equivalents, short-term investments, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow OLMA's reporting calendar. What is a balance sheet?